Posted by Michael Wonder on 13 Nov 2016
HHS watchdog office steps up focus on drug pricing
10 November 2016 - Seeking to address rising concerns about prescription medicines, the watchdog arm of the US Department of Health Human Services is adding to its list of pharmaceutical issues to be examined.
The HHS Office of Inspector General regularly compiles reports on such matters, whether in response to requests from Congress or to follow up issues, but is trying to widen its focus as questions accelerate about drug costs and the sources for some medicines, according to a new work plan released today.
